BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:26 PM
 | 
Aug 28, 2012
 |  BC Extra  |  Company News

FDA committee to discuss Heplisav for HBV

Dynavax Technologies Corp. (NASDAQ:DVAX) said FDA's Vaccines and Related Biological Products Advisory Committee will discuss a BLA for HBV product Heplisav at the...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >